Hasegawa E, Takeshige K, Oishi T, Murai Y, Minakami S
Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Biochem Biophys Res Commun. 1990 Aug 16;170(3):1049-55. doi: 10.1016/0006-291x(90)90498-c.
We studied the effects of 1-methyl-4-phenylpyridinium (MPP+), a metabolite of a parkinsonism-inducing drug, on the superoxide formation and the lipid peroxidation in bovine heart submitochondrial particles. The NADH-supported formation of superoxide radicals was induced by MPP+ at the concentration which is considered to exist in mitochondria of dopamine neurons. The formation increased as the NADH-ubiquinone reductase activity was inhibited by MPP+. The NADH-supported lipid peroxidation by the particles in the presence of ADP-Fe3+ chelate was also enhanced by MPP+ at similar concentrations. The formation was inhibited by succinate and the reduction of endogenous ubiquinone seems to be related to the inhibition. A possibility was discussed that the formation of superoxide anions and the lipid peroxidation may contribute in the cytotoxicity of the drug.
我们研究了一种诱发帕金森症药物的代谢产物1-甲基-4-苯基吡啶鎓(MPP+)对牛心亚线粒体颗粒中超氧化物形成和脂质过氧化的影响。MPP+在被认为存在于多巴胺能神经元线粒体中的浓度下,诱导了由NADH支持的超氧自由基形成。随着MPP+抑制NADH-泛醌还原酶活性,超氧自由基的形成增加。在类似浓度下,MPP+也增强了颗粒在ADP-Fe3+螯合物存在时由NADH支持的脂质过氧化。琥珀酸抑制了脂质过氧化的形成,内源性泛醌的还原似乎与这种抑制有关。文中讨论了一种可能性,即超氧阴离子的形成和脂质过氧化可能在该药物的细胞毒性中起作用。